Editorial

1. Comments on National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China(English version)

Perspective

1. Advances,breakthroughs,and challenges in gastric cancer surgery

Review Article

1. Epidemiology of pancreatic cancer: New version,new vision
2. MRD-directed and risk-adapted individualized stratified treatment of AML
3. Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine
4. Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy,safety,and biomarkers

Original Article

1. Genetic susceptibility loci of lung cancer are associated with malignant risk of pulmonary nodules and improve malignancy diagnosis based on CEA levels
2. A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer
3. Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
4. Genetic abnormalities assist in pathological diagnosis and EBVpositive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients
5. OpenNAU: An open-source platform for normalizing,analyzing,and visualizing cancer untargeted metabolomics data